Research

Displaying 191 - 200 of 315 Articles
MS Ireland/Novartis
19 Sep 2016

Siponimod

Novartis BAF312 reduces the risk of disability progression in pivotal phase III study in secondary progressive Multiple Sclerosis patients

The UCD School of Medicine/MS Ireland
29 Feb 2016

UCD School of Medicine Patient Educator Programme

The UCD School of Medicine is delighted to partner with MS Ireland in order to expand our Patient Educator Programme, which currently involves educators that were recruited with the help of Arthritis Ireland and the Irish Society for Colitis and Crohn’s Disease.

Top